Characterization of C4-2 Prostate Cancer Bone Metastases and Their Response to Castration

Journal of Bone and Mineral Research

Volumn 18, Issue 10, 2003, Pages 1882-1888

  Pfitzenmaier, Jesco ^a,b   Quinn, Janna E ^a   Odman, Austin M ^a   Zhang, Jian ^c   Keller, Evan T ^c   Vessella, Robert L ^a   Corey, Eva ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Animal; Bone; Metastasis; Models; Prostate specific antigen; Prostatic neoplasm

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CELL; BONE DENSITY; BONE DESTRUCTION; BONE DISEASE; BONE METASTASIS; BONE MINERAL; CASTRATION; CONTROLLED STUDY; MALE; MORPHOMETRICS; MOUSE; NONHUMAN; PROSTATE CANCER; TIBIA; TUMOR CELL;

ANIMALS; BONE AND BONES; BONE DENSITY; CASTRATION; CELL LINE, TUMOR; HUMANS; MALE; MICE; MICE, SCID; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TIBIA; TIME FACTORS;

EID: 0142147981     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2003.18.10.1882     Document Type: Article

References (18)

1. Jemal A, Thomas A, Murray T, Thun M 2002 Cancer statistics, 2002. CA Cancer J Clin 52:23-47.
2. Rigaud J, Tiguert R, Le Normand L, Karam G, Glemain P, Buzelin JM, Bouchot O 2002 Prognostic value of bone scan in patients with metastatic prostate cancer treated initially with androgen deprivation therapy. J Urol 168:1423-1426.
3. Oefelein MG, Ricchiuti VS, Conrad PW, Goldman H, Bodner D, Resnick MI, Seftel A 2002 Clinical predictors of androgen-independent prostate cancer and survival in the prostate-specific antigen era. Urology 60:120-124.
4. Thalmann GN, Anezinis PE, Chang SM, Zhau HE, Kim EE, Hopwood VL, Pathak S, von Eschenbach AC, Chung LW 1994 Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res 54:2577-2581.
5. Thalmann GN, Sikes RA, Wu TT, Degeorges A, Chang SM, Ozen M, Pathak S, Chung LW 2000 LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis. Prostate 44:91-103.
6. Wu TT, Sikes RA, Cui Q, Thalmann GN, Kao C, Murphy CF, Yang H, Zhau HE, Balian G, Chung LW 1998 Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines. Int J Cancer 77:887-894.
7. Wang M, Stearns ME 1991 Isolation and characterization of PC-3 human prostatic tumor sublines which preferentially metastasize to select organs in S. C. I. D. mice. Differentiation 48:115-125.
8. Shevrin DH, Kukreja SC, Ghosh L, Lad TE 1988 Development of skeletal metastasis by human prostate cancer in athymic nude mice. Clin Exp Metastasis 6:401-409.
9. Shevrin DH, Gorny KI, Kukreja SC 1989 Patterns of metastasis by the human prostate cancer cell line PC-3 in athymic nude mice. Prostate 15:187-194.
10. Klein KA, Reiter RE, Redula J, Moradi H, Zhu XL, Brothman AR, Lamb DJ, Marcelli M, Belldegrun A, Witte ON, Sawyers CL 1997 Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nat Med 3:402-408.
11. Berlin O, Samid D, Donthineni-Rao R, Akeson W, Amiel D, Woods VL Jr 1993 Development of a novel spontaneous metastasis model of human osteosarcoma transplanted orthotopically into bone of athymic mice. Cancer Res 53:4890-4895.
12. Corey E, Quinn JE, Bladou F, Brown LG, Roudier MP, Brown JM, Buhler KR, Vessella RL 2002 Establishment and characterization of osseous prostate cancer models: Intra-tibial injection of human prostate cancer cells. Prostate 52:20-33.
13. Nemeth JA, Harb JF, Barroso U Jr, He Z, Grignon DJ, Cher ML 1999 Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone. Cancer Res 59:1987-1993.
14. Villanueva AR, Mehr LA 1977 Modifications of the Goldner and Gomori one-step trichrome stains for plastic-embedded thin sections of bone. Am J Med Technol 43:536-538.
15. Roudier MP, Sherrard DJ, True LD, Ott-Ralph SM, Meligro C, Berrie M, Soo CCY, Felise DG, Quinn JE, Vessella R 2000 Heterogeneous bone histomorphometric patterns in metastatic prostate cancer. J Bone Miner Res 15:S567.
16. Zhang J, Dai J, Qi Y, Lin DL, Smith P, Strayhorn C, Mizokami A, Fu Z, Westman J, Keller ET 2001 Osteoprotegerin inhibits prostate cancer-induced osteoclastogenesis and prevents prostate tumor growth in the bone. J Clin Invest 107:1235-1244.
17. Harris KA, Weinberg V, Bok RA, Kakefuda M, Small EJ 2002 Low dose ketoconazole with replacement doses of hydrocortisone in patients with progressive androgen independent prostate cancer. J Urol 168:542-545.
18. Oefelein MG, Ricchuiti V, Conrad W, Seftel A, Bodner D, Goldman H, Resnick M 2001 Skeletal fracture associated with androgen suppression induced osteoporosis: The clinical incidence and risk factors for patients with prostate cancer. J Urol 166:1724-1728.